Aurobindo Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
7,932.07
7,787.95
7,715.77
7,514.30
7,406.40
Other Income Qtr Cr136.00220.93135.62162.52186.98
Operating Revenues Qtr7,796.077,567.027,580.157,351.787,219.42

*All values are in Cr.

Operating Expenses Qtr
6,229.93
5,947.45
5,907.34
5,750.47
5,845.98
Operating Profit Qtr
1,566.14
1,619.57
1,672.81
1,601.31
1,373.44
EBIDT Qtr Cr
1,702.14
1,840.50
1,686.32
1,763.83
1,560.42
Depreciation Qtr
382.28
404.18
354.33
423.27
417.50
Net Profit Qtr
817.38
919.22
908.75
936.29
757.18
Basic EPS Qtr
14.00
15.69
15.51
16.04
12.83
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -